Navigation Links
Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award
Date:3/18/2008

ed the growth of Alba Therapeutics since its inception in 2004, and his leadership has been characterized by methodical and rapid growth. Alba has grown into a thriving Baltimore biotechnology company with 45 employees in its headquarters at the University of Maryland BioPark, and this growth has been punctuated by a series of significant milestones including securing significant venture financing, rapid progress of Alba's clinical candidate (larazotide acetate) into Phase 2b clinical trials, and closure of a licensing and collaboration agreement worth up to $325 million with Shire Pharmaceuticals.

About Alba

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Alba's technology platform is based upon a key pathway that regulates the assembly and disassembly of tight junctions in cell barriers throughout the body. As a result of its unique technology platform, Alba is a leader in mucosal biology and has developed a pipeline of innovative therapeutic candidates that has the potential to modify the course of disease and significantly improve upon existing treatments for a wide range of diseases such as celiac disease, Crohn's disease, and Asthma/COPD or acute lung injury.

Contact: Bernard McDonald, PhD

Phone: 410-319-0780

E-mail: info@albatherapeutics.com

Web site: http://www.albatherapeutics.com


'/>"/>
SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
5. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
6. Nile Therapeutics, Inc. Adds to Executive Management Team
7. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
10. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
11. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Colo. , July 31, 2014 ... awardee today with $25,000 to fund a translational ... inception in 2011, the gift was presented at ... Annual Meeting in Colorado Springs, ... specialize in neurointerventional approaches to neurovascular conditions, SNIS ...
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... bearings are uniquely suited to prevent loss of lubrication ... the high temperatures . , Recently, a manufacturer ... engineers at Graphite Metallizing to overcome problems with movement ... operation, pans containing blocks of powder mixture are loaded ...
(Date:7/31/2014)... DUBLIN , July 31, 2014 ... the "Global Genomics Market 2014-2018" report to ... Genomics is the study of the genetic ... to be a strong basis for the discovery and ... of human diseases or health conditions. Genomics is supported ...
(Date:7/31/2014)... -- Smith & Nephew (LSE:SN, NYSE: SNN ... its entry into the forefoot market with the ... Comprised of three separate repair options, the HAT-TRICK ... and reconstruction, a metatarsal osteotomy guide, and a ... also known as hammer toe correction. ...
Breaking Biology Technology:SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4
... SAN DIEGO, Oct. 27 BioAtom Inc. (private) announced,today ... Investor Conference on,Tuesday, October 28, 2008 at 2:30 PM ... in San Diego, California., Myron Karasik, M.B.A., C.M.C., ... of BioAtom Inc. of Costa Mesa, CA, dedicated,to development ...
... YORK, Oct. 24 The day of true ... study confirms the efficacy of a,revolutionary egg selection ... a viable and reliable fertility preservation option., ... ReproCure, a,vanguard genetics products company, this process increases ...
... /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; ... therapy and oncology, today announced that it received ... Zentaris that during the 30,consecutive business days prior ... the,Company,s common shares had closed below the US$1.00 ...
Cached Biology Technology:BioAtom Inc. To Present at BIOCOM Investor Conference 2008 2Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality 2Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality 3Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality 4AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price 2AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price 3
(Date:7/31/2014)... An international team of scientists from Spain, France, ... rove beetle that is the oldest definitive member ... found in amber. The discovery and description were ... phase-contrast X-ray synchrotron imaging technique, which allows the ... amber. The new species is described in the ...
(Date:7/31/2014)... Edmond Becquerel first discovered the photovoltaic effect in 1839, ... power of sunlight for its own purposes. In a ... of the FASEB Journal , scientists ... power of sunlight by focusing on a naturally occurring ... evolution. This conservationor persistence over time and across speciessuggests ...
(Date:7/31/2014)... people are familiar with Hibiscus flowers- they are ... they are commonly planted in the landscape. Some, ... are endangered species. , Only a relatively few ... of an equally beautiful and intriguing related group ... "brother of Hibiscus". , Brother of Hibiscus species ...
Breaking Biology News(10 mins):Scientists shine bright new light on how living things capture energy from the sun 2Brother of Hibiscus is found alive and well on Maui 2
... researchers is examining a new vaccine method that may ... and his team of researchers is hoping to find ... smaller doses and require only one trip to the ... prepared from killed bacteria. The vaccinated person,s immune system ...
... of the future plan to confront the greatest scientific, ... inhabitants? This is the question being addressed at the ... Status and Perspective held by the Deutsche Forschungsgemeinschaft (DFG, ... Promotion of Science (JSPS), taking place in Hamburg this ...
... in French . A research ... Universitys Department of Microbiology and Immunology has discovered that ... the bodys autoimmune reactions may lose their effectiveness and ... type 1 diabetes. The study conducted on non-obese ...
Cached Biology News:Iowa State researchers look for smaller, cheaper, 1-dose vaccines 2Japanese and German researchers meet to discuss climate change 2Japanese and German researchers meet to discuss climate change 3Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers 2